Clinical trial
A Phase 1 Study to Explore the Cardiac Pharmacodynamics of MT-1303
NCT02193217
Study timeline
Registry last updated2015-02-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Relapsing-remitting Multiple Sclerosisunresolved
Interventions
Sponsors & collaborators
Tanabe Pharma Corporationlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02193217 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.